Overexpression of ROR1-AS1 lncRNA promoted growth of MCL cells and resistance to ibrutinib (BTK inhibitor) and dexamethasone treatment through regulation of SOX11 and P16 expression. This evidence concerns the gene ROR1 and mantle cell lymphoma.